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Abstract
Background: Hypogammaglobulinemia in early childhood is a common feature characterized by distinct
intrinsic and extrinsic factors leading to disturbed peripheral blood lymphocyte homeostasis. Detailed flow
cytometric immunophenotyping of the peripheral blood B cell compartment is an informative tool for
delineating disturbed generation of B cell subpopulations crucial for the diagnosis of
hypogammaglobulinemia in young children.
Methods: We analyzed by flow cytometry the proportions and absolute values of total, naïve, memory - non-
switched and switched, transitional and immature B lymph cells as well as plasmablasts in the peripheral
blood of 50 hypogammaglobulinemic children aged from 3 to 50 months.
Results: Beyond physiological, age-related changes within the B cell pool, a proportion of children manifested
defective differentiation into switched memory and accumulation of CD21lo immature B cells.
Conclusions: Dynamic shifts within B cell subpopulations of the immature immune system being most
prominent during the first two years of life contribute to the age-related developmental abnormalities of
the B cell compartment. Therefore, a reliable diagnosis of common variable immunodeficiency (CVID) in
young hypogammaglobulinemic children cannot yet be established despite their clinical and immunological
phenotypes sharing common features with this primary immunodeficiency.
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Background
Hypogammaglobulinemia in infancy and early childhood
is a heterogeneous disorder of complex pathogenesis,
heterogeneous immunophenotype, a diverse clinical
course and prognosis. The antibody production defect is a
common feature characterized by distinct intrinsic and
extrinsic factors leading to disturbed peripheral blood
lymphocyte homeostasis. The developmental stages of the
peripheral blood B lymph cell compartment during
ontogeny encompass maturation and differentiation in an
age-dependent manner, accompanied by an expression of
specific immune surface and intracellular markers. This
highly regulated multistep process commences in the
bone marrow and is continued in the peripheral lymphoid
organs, such as follicles and germinal centres of spleen
and lymph nodes, as well as in the marginal zone of the
spleen and underlies the composition of the peripheral
blood lymphocyte compartment with distinct B cell
subpopulations. The B cells outside the bone marrow are
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morphologically homogenous, but their surface pheno-
types, anatomical localization, and functional properties
are complex [1–3] and further substantial additional
complexity can be revealed by a multichromatic flow
cytometric approach. These circulating peripheral blood
(PB) B lymphocytes can be classified according to their
maturity stage into: immature/transitional, naïve, memory
B cells, and plasmablasts/plasma cells. Flow cytometric
immunophenotyping of peripheral blood B lymph cell
compartment is a meaningful and informative tool for
delineating maturation of B cell subpopulations, formation
of mature B cells which enter the blood and migrate to
peripheral lymphoid organs to undergo antigen-dependent
activation and further differentiation to play an essential
role in the adaptive immune response. The impaired B-cell
development and maturational B-cell arrest and a lack of
further developmental stages of B-cell lineage are asso-
ciated with certain primary immunodeficiencies with hypo-
gammaglobulinemia and lack of B-cell memory [4–8].
Profound panhypogammaglobulinemia with the pres-
ence of newly arisen B cells is observable in common
variable immunodeficiency (CVID), a heterogeneous dis-
order in which the hallmark of the immunological pheno-
type is a reduction of class-switched memory B cell subset
along with the accumulation of immature B cells and
impaired further differentiation into plasma cells [9–11].
As the unique dynamic developmental changes in the B
cell compartment are observable in infancy and early
childhood, they must be taken into account when inter-
preting data from B cell immunophenotyping in pediatric
populations [1, 12–15].
The aim of the study was to understand better the
pathogenesis of hypogammaglobulinemia in infancy and
early childhood based on an assessment of the peripheral
blood B cell subpopulations. The evaluation of the rela-
tionship between an antibody production defect and B
cell compartment will be helpful in defining the nature
of the disease and its prognosis.
Methods
Study group
We performed a retrospective review of medical records of
fifty infants and young children, 36 boys and 14 girls, aged
between 3 months and 4 years (mean age 16 months,
median age 14 months), who had been referred to the
pediatric pneumonology, allergology and immunology
university clinic because of recurrent respiratory tract infec-
tions for the purpose of differential diagnosis towards PIDs,
from July through December 2014. In all the children
studied hypogammaglobulinemia, below 2SD of the lower
limit of age-matched reference values, regarding either
exclusively IgG or combined IgG and one or two immuno-
globulin isotypes, had been assessed.
Assessment of antibody levels
The serum samples obtained from clotted peripheral
blood were used for further analysis of the major classes
of immunoglobulins. Immunoglobulin G, A, and M levels
were measured with the use of an immunoturbidymetric
assay (Beckman Coulter, USA).
Cell preparation and peripheral blood flow cytometric
immunophenotyping
Peripheral venous blood samples anticoagulated with
ethylenediaminetetracetic acid (EDTA-K2) were stored at
a temperature of between 4 and 8°C and processed within
24 hours. Cells were labelled with the following murine
fluorochrome-stained monoclonal antibodies: anti-CD45
FITC (fluoresceineisothiocyanate), anti-CD14 PE (phy-
coerithrin), anti-CD19 PE, anti-CD19 PerCP (peridinin
chlorophyll protein), anti-IgM FITC, anti-IgD FITC, anti-
CD38 APC (allophycocyanin), anti-CD27 PE, and anti-
CD21 FITC (Beckton-Dickinson, USA). Blood samples
were mixed with antibodies, incubated in a lysing solution
(FACS Lysing Solution, Beckton-Dickinson, USA), centri-
fuged twice and suspended in a phosphate buffered saline
(PBS, Roche, Germany). The acquisition of cells and ana-
lysis were carried out with the use of the flow cytometer
FACSCanto and FACSDiva software (Beckton-Dickinson,
USA). With sequential gating on biparametric scattering
CD45hiCD14- lymphocytes, the following B lymph cell
subpopulations were identified: memory B cells CD19
+CD27+, naïve B cells CD19+CD27-, non-switched mem-
ory B cells / marginal zone B cells CD19+CD27+IgD+,
switched memory B cells CD19+CD27+IgD-, transitional B
cells CD19+CD38hiIgMhi, plasmablasts CD19+CD38+IgM-,
and immature B cells CD19+CD21lo and CD19+CD21lo
CD38lo. The relative values of peripheral blood lympho-
cytes, the B cells of the total lymphocyte population and B
cell subsets were calculated. The absolute counts of all cell
subsets were calculated from the leukocyte count obtained
from the analyzer XT 2000i (SYSMEX, Japan). A com-
parative analysis was done with a group of 111 healthy
children aged from 5 months to 5 years, the peripheral
blood B lymph cells immunophenotyping of whom had
been carried out by Piatosa et al [14] and served to elabo-
rate the reference cut-off values for pediatric populations
at different age groups.
Statistical analysis
The statistical analysis was conducted with the use of R
3.2.0 software. To compare sex distributions, Pearson’s chi-
squared (χ2) tests were immediately employed. For the
purpose of comparing other parameters, intervals based on
median reference values in the control group (given in the
study by Piatosa et al [14]) were created and subsequently,
intervals in the study group were formed. To determine
statistical differences between frequency distributions, a
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fourfold table and the χ2 test were applied. P values < 0.05
were admitted as statistically significant.
Results
The analysis of demographic data of both the study group
and the control group did not reveal statistically signifi-
cant differences regarding sex and age distributions, vali-
dating the reference to age-dependent limits of a normal
range, as elaborated by Piatosa et al [14].
Within the total lymph cell pool, the relative frequency
of the B cell population in the peripheral blood (Fig. 1a)
was increased above the reference values in as much as 29
(58 %) of the children studied and it was statistically
significant in children aged from 9 months to 15 months
and from 15 months to 24 months (p = 0.002 and p =
0.029, respectively). At the same time it maintained within
the normal range in 17 (34 %) of children and was
decreased below the lower limit in only 4 (8 %) children.
The tendency to increased B cell relative frequency was
accompanied by a normal absolute B cell count (Fig. 1b),
which was assessed in as many as 37 (74 %) of the chil-
dren studied.
The total memory B cell subset was within age-matched
limits both in terms of relative value and in terms of an
absolute count in 32 (64 %) and 37 (74 %) of the children
studied, respectively (Fig. 2a and 2b). A decrease in the
absolute count of the total memory B cell population
occurred admittedly in only 6 (12 %), but in groups of
children aged from 15 to 24 months and from 24 to 60
months the decrease of a memory B cell number was
statistically significant (p = 0.029 and p = 0.024, respec-
tively). The relative memory B cell frequency was de-
creased in 11 (22 %) of the children studied and in
children aged from 24 to 60 months it was statistically
significant (p = 0.0245). The impaired B cell memory was
accompanied by an increase both in the relative frequency
and absolute number of naïve B cells in 7 (14 %) of the
children. The increase of the relative frequency of naïve B
cells was observable in three age groups: in children from
9 to 15 months, from 15 to 24 months as well as from 24
to 60 months of age and it was statistically significant
(p values 0.043, 0.029 and 0.0245, respectively).
Within the memory B cell pool, non-switched (marginal
zone-like, MZL) and switched memory cells were distin-
guished. The relative frequency of MZL B cells (Fig. 2c)
was decreased in total in as many as 22 (44 %) children,
whereas in children aged from 9 to 15 months and in
children aged from 15 to 24 months the decrease of MZL
B cells compared to the control group was statistically
significant (p values 0.012 and 0.001, respectively). The
absolute count of MZL B cells was decreased in 10 (20 %)
of the children studied and again, in the group of older
patients, from 15 to 24 months of age, the decrease of the
MZL B cell subset was statistically significant (p = 0.007).
The switched memory B cell subset in general main-
tained within the normal age-matched range in terms of
both relative value and absolute count (Fig. 2e and 2f,
respectively) in 38 (76 %) patients. However, the decrease
of relative values and absolute numbers of this B cell
subset that was observed in total in 12 (24 %) patients,
was statistically significant in the older age group, namely
in children aged from 9 to 15 months and from 24 to 60
months (p = 0.043 and p = 0.025, respectively).
A transitional B cell subset, in turn, showed a tendency
to increase its relative frequency (Fig. 3a) in 10 (20 %) and
the absolute count (Fig. 3b) in 12 (24 %) the children
studied and again, the increase of the relative frequency of
transitional B cells was statistically significant (p = 0.004)
in children aged from 24 to 60 months. The absolute
count as well as the relative frequency of transitional B
cells maintained normal in 30 (60 %) and 29 (58 %) of
patients, respectively.
The percentage of the immature B cell pool, defined
as CD19+CD21lo, was below the age-matched cut-off
values in 10 (20 %) of the children studied and of these,
9 were children aged less than 18 months. The immature
B cell subset was further specified by their expression of
CD38. The increased percentage and the absolute count
above the age-matched reference values of the CD19
+CD21loCD38lo B cell subset was apparent in 29 (58 %) of
Fig. 1 The relative frequency (a) and the absolute count (b) of the total B cell pool in hypogammaglobulinemic children
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the children studied (Fig. 3c and 3d, respectively). How-
ever, it is worth noting that the expansion of these more
immature B cells was observable in as much as 26 of chil-
dren aged from 3 to 17 months, but it was statistically sig-
nificant in the group of patients aged between 24 and 60
months (p = 0.004).
Interestingly, the number and the relative frequency of
plasmablasts was increased above the reference values in
13 (26 %) patients and maintained within the normal
range in 31 (62 %) and 29 (58 %) of all our hypogamma-
globulinemic children, respectively. However, a distribu-
tion of the absolute count of plasmablasts reaching both
the lower or higher limit of the normal range can be no-
ticed, but the analysis did not reveal the statistical signifi-
cance in any age group of the children studied.
Discussion
Diagnostic criteria of the vast majority of primary im-
munodeficiencies with antibody production defects are
based on anamnesis which includes family history and
individual medical history, a clinical manifestation of the
disease and the exclusion of other diagnoses causing
secondary hypogammaglobulinemia. Antibody production
defects are the most common and the largest group of
primary immunodeficiency disorders in children, with
heterogeneity of the clinical course and prognosis, ranging
from mild or even asymptomatic selective IgA deficiency
or transient hypogammaglobulinemia of infancy (THI) to
very severe agammglobulinemias with the profound
inability to mount the antigen-specific humoral immune
response [16]. Peripheral blood lymph cell immunotyping
with assessment of B cell pool maturation is an important
step in the differential diagnosis of symptomatic hypogam-
maglobulinemia and particularly in common variable
immunodeficiency (CVID) abnormalities in B cell subsets
have been identified [17, 18]. Depending on the relative
frequency of peripheral blood class-switched memory B
cells, Freiburg [19], Paris [20] and EUROclass [9] classifi-
cation schemes have been proposed in order to find the
correlation between B lymph cell maturational defects and
Fig. 2 The immunophenotypic distribution of memory B cells in the children studied: the relative frequency (a) and the absolute count
(b) of the total memory B cell pool, non-switched memory B cells (c and d) and the switched memory B cell subpopulation (e and f)
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clinical manifestation and to identify patients with a high
risk of specific complications, such as autoimmunity,
splenomegaly and granulomatous disease. However, taking
into consideration the maturational development of the
immune competence in children, with the most dynamic
shifts among lymph cell subsets in peripheral blood reflect-
ing structural and functional maturation of central and
peripheral immune organs, the predictive role of class-
switched memory B cells in pediatric patients with anti-
body production defects may be called into question [21].
In our study the hypogammaglobulinemic children mani-
fested diverse maturational defects within the B lymph cell
pool. Firstly, in a large group of them, an increase of the
total B cell relative frequency was observable. Interestingly,
it was statistically significant in children between 9 and 24
months, but not in young infants between 2 and 9 month
of age. Similarly, Dorsey and Orange reported an increase
in the B cell percentage in a group of 24 children with IgG
hypogammaglobulinemia and / or decreased other im-
munoglobulin izotypes [22]. The authors suggested the
increased B lymph cell proportion was a characteristic
feature of transient hypogammaglobulinemia of infancy and
concluded that THI is associated with different abnorma-
lities regarding B cell-related immune response beyond just
hypogammaglobulinemia. While the number and relative
frequency of the total B lymph cell pool is not widely
considered in children as an exclusive predictive factor of
possible development of CVID in hypogammaglobulinemic
children, Aydogan et al [23] nevertheless considered a
decrease in the percentage of the B cell number as an
important immunologic parameter for identifying pediatric
CVID patients at risk of respiratory complications. In the
studies by Piatosa et al [24] and by Bukowska-Strakova et al
[25] the authors showed a decrease in the total number of
B cells in a proportion of pediatric CVID patients. As in the
latter study, THI children had normal number and relative
frequency of total B cells, so the authors concluded that
hypogammaglobulinemia in THI results rather from in-
appropriate immunoregulation than with disturbance in
development of the B cell compartment.
Considering the clinical heterogeneity of antibody defi-
ciencies and peculiar obstacles in establishing a definitive
diagnosis in children aged less than 5 years, a detailed
immunophenotypic examination of the B-cell subpopula-
tions with the use of age-specific cut-off reference values
is of critical importance, but none of the above mentioned
classification schemes clearly defines such age-matched
values. Whereas many authors admittedly recommend an
analysis of the memory B cell population to facilitate the
diagnosis of CVID in pediatric patients [25–30], Smet et
al [21] showed that the EUROclass limit of 2 % of B cells
being switched memory [9] as well as the Freiburg limit of
0.4% of switched memory B cells among total peripheral
blood B cells [19] were already reached by healthy chil-
dren from 1 year of age onwards. Nonetheless, the authors
pointed out the cut-off value of 8 % of switched memory
B cells obtained in an adult cohort by the French group
[20] was not suitable for healthy children even between
Fig. 3 The relative frequency and the absolute count of transitional B cells (a and b) and immature B cells with low expression of CD21 (c and d)
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the ages of 10 and 15 years, but their limit value of 11%
for total memory B cells appeared to be applicable from
the age of 2 years upwards.
In our study group, in 10 children aged 24 month or
more, 6 (60 %) of them had a total memory B cell percen-
tage lower than 11 and in this age group the memory B
cell deficiency was statistically significant. Compared to
the control group, the memory B cell frequency was below
the age-matched limit in 11 (22 %) of all hypogammaglo-
bulinemic children studied in general, but in children
younger than 15 month of age it was not statistically
significant.
The switched memory B cell subpopulation reached the
limit of 0.4 % among total B cell pool in all our children
studied and the relative value of switched memory cells
was below 2 % in 5 patients, aged from 3 to 12 months,
but not in any children studied from the age of 1 year
upwards. As was stressed by Smet et al [21], the particular
limits of B cell subpopulations admitted as a diagnostic
criteria by EUROclass and Freiburg classifications may be
applicable even for young children, but a French classifi-
cation has more limitations if applied to children.
As was shown by Bukowska-Strakova et al [25] and
Karaca et al [31], patients with THI do not show substan-
tial abnormalities regarding the peripheral blood B cell
pool and the percentage of memory B cells remains within
the age-matched limits. Similarly, in a group of children
with the initial diagnosis of THI reported by Moschese et
al [32], most of these patients recovered from hypogam-
maglobulinemia by the age of 24 months and did not
show a deficiency in switched memory B cells. These chil-
dren, who did not normalize their immunoglobulin levels
by the age of 24 months, expressed a reduced frequency
of switched memory B cell pool and shared clinical and
immunological profiles similar to other primary immune
deficiencies with antibody production defects. In the
children studied, we did not find a significant correlation
between the severity of hypogammaglobulinemia, in
particular IgG deficiency, and defective development of
any B cell population.
In a proportion of CVID patients, an observable B cell
maturation defect with reduced switched memory B cell
development is also associated with expansion of transi-
tional CD19+CD38hiIgMhi and CD21 positive B cells or
more immature B cell subset with low expression of CD21
maturation marker [33, 34], which correlated with clinical
phenotypes such as lymphadenopathy and splenomegaly
as well as autoimmune cytopenias [35]. Importantly, the
abnormally high percentage of these CD21lo transitional B
cells in circulation which was shown in infants in our
study group may be observed during the first years of life
and is attributable to immaturity of the immune system in
the early childhood [36–39]. As the evolution of percen-
tages of CD21lo B cells is age-related, application of
EUROclass criteria regarding this immature B cell subset
for the diagnosis of B cell dysfunction requires careful
standardization of flow cytometry evaluation of B cell
maturation and for the purpose to its use as a prognostic
marker of immunodeficiency in children.
Certainly, a lack of the follow-up of the study group that
could add more significance to the immunological data is
the major drawback of the presented study. However,
assessment of the B cell subsets of our children can be
considered as a screening evaluation for the purpose to
identifying high-risk patients who require regular follow-
up visits and further evaluation of their immune system.
Conclusions
The greatest and the most dynamic developmental and
maturational changes among B cell subsets occur in
children below the age of 2 years. The immaturity of the
immune system in the infancy and early childhood
contribute to the age-related B lymphocyte abnormalities.
Therefore, the reliable diagnosis of CVID in hypogamma-
globulinemic children aged less than 2 years cannot yet be
established despite their clinical and immunological
phenotypes sharing common features with this disease
entity. It needs to be highlighted that the classifications
used in adults cannot be applied to children with antibody
production defects who therefore require separate diag-
nostic and prognostic criteria.
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